Cargando…

Circulating Blood-Based Biomarkers in Pulmonary Hypertension

Pulmonary hypertension (PH) is a serious hemodynamic condition, characterized by increased pulmonary vascular resistance (PVR), leading to right heart failure (HF) and death when not properly treated. The prognosis of PH depends on etiology, hemodynamic and biochemical parameters, as well as on resp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Banaszkiewicz, Marta, Gąsecka, Aleksandra, Darocha, Szymon, Florczyk, Michał, Pietrasik, Arkadiusz, Kędzierski, Piotr, Piłka, Michał, Torbicki, Adam, Kurzyna, Marcin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8779219/ https://www.ncbi.nlm.nih.gov/pubmed/35054082 http://dx.doi.org/10.3390/jcm11020383

Ejemplares similares

Soluble ST2 as a Biomarker for Early Complications in Patients with Chronic Thromboembolic Pulmonary Hypertension Treated with Balloon Pulmonary Angioplasty
por: Banaszkiewicz, Marta, et al.
Publicado: (2021)

Assessment of Clinical Usefulness of Resting Electrocardiogram (PH-ECG Score) in Monitoring the Efficacy of Balloon Pulmonary Angioplasty (BPA) in Patients with Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
por: Piłka, Michał, et al.
Publicado: (2021)

Assessment of electrocardiographic markers of acute and long‐term hemodynamic improvement in patients with pulmonary hypertension
por: Piłka, Michał, et al.
Publicado: (2020)

An unusual case of CTEPH treated by BPA in a patient with a single lung after cancer surgery
por: Darocha, Szymon, et al.
Publicado: (2022)

Emerging Role of Balloon Pulmonary Angioplasty in Chronic Thromboembolic Pulmonary Disease—Insights from the 2022 ESC Guidelines
por: Banaszkiewicz, Marta, et al.
Publicado: (2023)

Balloon Pulmonary Angioplasty with Stent Implantation as a Treatment of Proximal Chronic Thromboembolic Pulmonary Hypertension
por: Darocha, Szymon, et al.
Publicado: (2020)

Prediction of Prognostic Hemodynamic Indices in Pulmonary Hypertension Using Non-Invasive Parameters
por: Mańczak, Rafał, et al.
Publicado: (2020)

Characteristics and Outcomes of Patients Consulted by a Multidisciplinary Pulmonary Embolism Response Team: 5-Year Experience
por: Pietrasik, Arkadiusz, et al.
Publicado: (2022)

Catheter-Based Therapies Decrease Mortality in Patients With Intermediate and High-Risk Pulmonary Embolism: Evidence From Meta-Analysis of 65,589 Patients
por: Pietrasik, Arkadiusz, et al.
Publicado: (2022)

Hybrid treatment of massive pulmonary embolism by catheter-directed and surgical embolectomy
por: Pietrasik, Arkadiusz, et al.
Publicado: (2021)

Balloon Pulmonary Angioplasty in Technically Operable and Technically Inoperable Chronic Thromboembolic Pulmonary Hypertension
por: Darocha, Szymon, et al.
Publicado: (2021)

Predictive value of chest HRCT for survival in idiopathic pulmonary arterial hypertension
por: Kacprzak, Aneta, et al.
Publicado: (2021)

Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension
por: Kurzyna, Marcin, et al.
Publicado: (2015)

Catheter-directed therapy to treat intermediate- and high-risk pulmonary embolism: Personal experience and review of the literature
por: Pietrasik, Arkadiusz, et al.
Publicado: (2022)

Acute and chronic dissection of pulmonary artery: new challenges in pulmonary arterial hypertension?
por: Florczyk, Michał, et al.
Publicado: (2017)

Fear of COVID-19, Anxiety and Depression in Patients with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension during the Pandemic
por: Wieteska-Miłek, Maria, et al.
Publicado: (2021)

Expert opinion on the creating and operating of the regional Pulmonary Embolism Response Teams (PERT). Polish PERT Initiative
por: Araszkiewicz, Aleksander, et al.
Publicado: (2020)

Prostacyclin Analogues Inhibit Platelet Reactivity, Extracellular Vesicle Release and Thrombus Formation in Patients with Pulmonary Arterial Hypertension
por: Gąsecka, Aleksandra, et al.
Publicado: (2021)

Treatment of chronic thromboembolic pulmonary hypertension in a multidisciplinary team
por: Siennicka, Anna, et al.
Publicado: (2019)

Precision medicine: The future of diagnostic approach to pulmonary hypertension?
por: Kedzierski, Piotr, et al.
Publicado: (2019)

COVID-19 Vaccination in Patients with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension: Safety Profile and Reasons for Opting against Vaccination
por: Wieteska-Miłek, Maria, et al.
Publicado: (2021)

Physical Activity in Pulmonary Arterial Hypertension during Pandemic COVID-19 and the Potential Impact of Mental Factors
por: Wieteska-Miłek, Maria, et al.
Publicado: (2022)

Long COVID syndrome after SARS‐CoV‐2 survival in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
por: Wieteska‐Miłek, Maria, et al.
Publicado: (2023)

Characterization of Patients with Pulmonary Arterial Hypertension: Data from the Polish Registry of Pulmonary Hypertension (BNP-PL)
por: Kopeć, Grzegorz, et al.
Publicado: (2020)

Catheter-directed mechanical aspiration thrombectomy in a real-world pulmonary embolism population: a multicenter registry
por: Sławek-Szmyt, Sylwia, et al.
Publicado: (2023)

Dominating Cause of Pulmonary Hypertension May Change Over Time—Diagnostic and Therapeutic Considerations in a Patient with Pulmonary Hypertension Due to Rheumatoid Arthritis with Lung Involvement
por: Szturmowicz, Monika, et al.
Publicado: (2021)

Characteristics and outcomes of patients with chronic thromboembolic pulmonary hypertension in the era of modern therapeutic approaches: data from the Polish multicenter registry (BNP-PL)
por: Kopeć, Grzegorz, et al.
Publicado: (2021)

CTLA-4 Expression Is a Promising Biomarker of Idiopathic Pulmonary Arterial Hypertension and Allows Differentiation of the Type of Pulmonary Hypertension
por: Tomaszewski, Michał, et al.
Publicado: (2022)

Biomarker-based approach to determine etiology and severity of pulmonary hypertension: Focus on microRNA
por: Rogula, Sylwester, et al.
Publicado: (2022)

An implantable pump Lenus pro® in the treatment of pulmonary arterial hypertension with intravenous treprostinil
por: Kurzyna, Marcin, et al.
Publicado: (2017)

The multiple systemic artery to pulmonary artery fistulas resulting in severe irreversible pulmonary arterial hypertension in patient with previous history of pneumothorax
por: Jacheć, Wojciech, et al.
Publicado: (2019)

Impact of the COVID-19 Pandemic on Pulmonary Hypertension Patients: Insights from the BNP-PL National Database
por: Mamzer, Aleksandra, et al.
Publicado: (2022)

Haemodynamic monitoring in acute heart failure – what you need to know
por: Jasińska-Gniadzik, Karolina, et al.
Publicado: (2022)

Percutaneous removal of a catheter fragment from the right atrium
por: Pietrasik, Arkadiusz, et al.
Publicado: (2021)

Effect of Statins on All-Cause Mortality in Adults: A Systematic Review and Meta-Analysis of Propensity Score-Matched Studies
por: Nowak, Marcin M., et al.
Publicado: (2022)

Challenging two-staged percutaneous coronary intervention in multivessel coronary artery disease with a high SYNTAX score: feasible, yet complicated
por: Gąsecka, Aleksandra, et al.
Publicado: (2021)

Iatrogenic subclavian artery puncture repair with Angio-Seal deployment and balloon occlusion
por: Gąsecka, Aleksandra, et al.
Publicado: (2021)

Pulmonary Hypertension: Diagnosis and Management
por: Torbicki, Adam
Publicado: (2021)

Milestones in Understanding Pulmonary Circulation: From Antiquity to Heart-Lung Machine
por: Torbicki, Adam
Publicado: (2021)

High CD200 Expression on T CD4+ and T CD8+ Lymphocytes as a Non-Invasive Marker of Idiopathic Pulmonary Hypertension–Preliminary Study
por: Tomaszewski, Michał, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0vce3i0gi1f8rfju92339amcui